Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ornithine Aspartic Acid Granules vs Silymarin Capsules in NAFLD
NCT05042245Phase 4Completed
- Sponsor
- Xinhua Hospital
- Start
- Jul 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of l-ornithine l-aspartate in non-alcoholic fatty liver disease (NAFLD), sponsored by Xinhua Hospital. Started Jul 2019; status: completed.
02
Drugs
l-ornithine l-aspartate
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT05042245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05042245.